ArticleInvestigational new drugs2025

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.

Susy Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.